NPORT-EX 3 NPORT_5257144733737999.htm
Quarterly Report
November 30, 2020
MFS®  Value Fund
EIF-Q1

Portfolio of Investments
11/30/20 (unaudited)
The Portfolio of Investments is a complete list of all securities owned by your fund. It is categorized by broad-based asset classes.
Issuer     Shares/Par Value ($)
Common Stocks – 98.5%
Aerospace – 6.5%  
Honeywell International, Inc.   7,220,491 $1,472,402,525
Lockheed Martin Corp.   1,467,831 535,758,315
Northrop Grumman Corp.   3,461,125 1,046,159,642
Raytheon Technologies Corp.   5,011,489 359,423,991
        $3,413,744,473
Alcoholic Beverages – 1.4%  
Diageo PLC   19,420,459 $743,855,907
Brokerage & Asset Managers – 3.4%  
BlackRock, Inc.   1,091,963 $762,572,361
NASDAQ, Inc.   5,810,731 743,715,460
T. Rowe Price Group, Inc.   2,128,397 305,233,414
        $1,811,521,235
Business Services – 6.4%  
Accenture PLC, “A”   5,528,524 $1,377,100,043
Equifax, Inc.   2,705,249 451,506,058
Fidelity National Information Services, Inc.   5,006,373 742,995,817
Fiserv, Inc. (a)   6,837,941 787,594,045
        $3,359,195,963
Cable TV – 3.3%  
Comcast Corp., “A”   34,673,691 $1,742,006,236
Chemicals – 1.9%  
PPG Industries, Inc.   6,751,691 $990,945,688
Construction – 3.7%  
Masco Corp.   7,987,461 $428,687,032
Otis Worldwide Corp.   2,505,744 167,734,503
Sherwin-Williams Co.   893,137 667,736,015
Stanley Black & Decker, Inc.   3,620,408 667,277,399
        $1,931,434,949
Consumer Products – 1.6%  
Colgate-Palmolive Co.   1,413,080 $121,016,171
Kimberly-Clark Corp.   3,318,354 462,279,896
Reckitt Benckiser Group PLC   2,754,229 241,751,382
        $825,047,449
Electrical Equipment – 1.1%  
Johnson Controls International PLC   13,021,923 $599,529,335
Electronics – 5.2%  
Analog Devices, Inc.   2,836,285 $394,470,518
Intel Corp.   9,013,930 435,823,515
NXP Semiconductors N.V.   3,521,902 557,939,715
Texas Instruments, Inc.   8,470,751 1,365,908,599
        $2,754,142,347
1

Portfolio of Investments (unaudited) – continued
Issuer     Shares/Par Value ($)
Common Stocks – continued
Energy - Independent – 1.4%  
ConocoPhillips   8,579,080 $339,388,405
EOG Resources, Inc.   4,505,632 211,224,028
Pioneer Natural Resources Co.   1,902,018 191,304,970
        $741,917,403
Energy - Integrated – 0.5%  
Chevron Corp.   3,224,170 $281,083,141
Food & Beverages – 3.7%  
Archer Daniels Midland Co.   6,283,050 $312,707,398
Danone S.A.   2,799,820 179,322,752
J.M. Smucker Co.   1,251,434 146,668,065
Nestle S.A.   8,178,243 912,594,104
PepsiCo, Inc.   2,652,016 382,500,268
        $1,933,792,587
Gaming & Lodging – 0.4%  
Marriott International, Inc., “A”   1,557,666 $197,621,085
Health Maintenance Organizations – 2.3%  
Cigna Corp.   5,690,792 $1,190,172,239
Insurance – 8.0%  
AON PLC   5,901,856 $1,209,231,276
Chubb Ltd.   7,509,780 1,110,170,778
Marsh & McLennan Cos., Inc.   8,639,955 990,484,441
Travelers Cos., Inc.   7,152,079 927,267,042
        $4,237,153,537
Machinery & Tools – 4.6%  
Eaton Corp. PLC   6,684,174 $809,520,313
Illinois Tool Works, Inc.   4,743,462 1,001,297,394
Trane Technologies PLC   4,099,694 599,539,250
        $2,410,356,957
Major Banks – 7.5%  
Goldman Sachs Group, Inc.   3,709,587 $855,356,570
JPMorgan Chase & Co.   18,694,733 2,203,735,126
PNC Financial Services Group, Inc.   4,240,766 585,522,562
State Street Corp.   4,560,562 321,428,410
        $3,966,042,668
Medical & Health Technology & Services – 1.0%  
McKesson Corp.   2,880,154 $518,168,506
Medical Equipment – 9.0%  
Abbott Laboratories   7,655,499 $828,478,102
Boston Scientific Corp. (a)   12,866,900 426,537,735
Danaher Corp.   4,147,532 931,660,113
Medtronic PLC   13,450,116 1,529,278,189
Thermo Fisher Scientific, Inc.   2,225,675 1,034,894,362
        $4,750,848,501
Other Banks & Diversified Financials – 6.0%  
American Express Co.   5,330,165 $632,104,267
Citigroup, Inc.   17,866,055 983,883,649
Moody's Corp.   1,046,860 295,570,453
Truist Financial Corp.   11,108,789 515,669,985
2

Portfolio of Investments (unaudited) – continued
Issuer     Shares/Par Value ($)
Common Stocks – continued
Other Banks & Diversified Financials – continued  
U.S. Bancorp   17,092,042 $738,547,135
        $3,165,775,489
Pharmaceuticals – 7.2%  
Johnson & Johnson   13,261,125 $1,918,619,565
Merck & Co., Inc.   8,504,741 683,696,129
Pfizer, Inc.   24,340,052 932,467,392
Roche Holding AG   735,084 241,587,734
        $3,776,370,820
Railroad & Shipping – 2.2%  
Canadian National Railway Co.   3,205,003 $343,095,571
Union Pacific Corp.   4,027,584 821,949,343
        $1,165,044,914
Real Estate – 0.3%  
Public Storage, Inc., REIT   828,428 $185,948,949
Specialty Chemicals – 0.8%  
DuPont de Nemours, Inc.   6,449,547 $409,159,262
Specialty Stores – 1.3%  
Lowe's Cos., Inc.   4,241,067 $660,843,060
Telephone Services – 0.5%  
Verizon Communications, Inc.   4,039,343 $244,016,711
Tobacco – 0.5%  
Philip Morris International, Inc.   3,164,047 $239,676,560
Utilities - Electric Power – 6.8%  
American Electric Power Co., Inc.   5,151,061 $437,273,568
Dominion Energy, Inc.   8,673,667 680,796,123
Duke Energy Corp.   12,974,192 1,202,188,631
Southern Co.   16,057,402 961,035,509
Xcel Energy, Inc.   4,516,977 304,263,571
        $3,585,557,402
Total Common Stocks   $51,830,973,373
Investment Companies (h) – 1.2%
Money Market Funds – 1.2%  
MFS Institutional Money Market Portfolio, 0.1% (v)     650,034,619 $650,034,619
 
Other Assets, Less Liabilities – 0.3%   157,619,135
Net Assets – 100.0% $52,638,627,127
(a) Non-income producing security.      
(h) An affiliated issuer, which may be considered one in which the fund owns 5% or more of the outstanding voting securities, or a company which is under common control. At period end, the aggregate values of the fund's investments in affiliated issuers and in unaffiliated issuers were $650,034,619 and $51,830,973,373, respectively.      
(v) Affiliated issuer that is available only to investment companies managed by MFS. The rate quoted for the MFS Institutional Money Market Portfolio is the annualized seven-day yield of the fund at period end.      
The following abbreviations are used in this report and are defined:
REIT Real Estate Investment Trust
See attached supplemental information. For more information see notes to financial statements as disclosed in the most recent semiannual or annual report.
3

Supplemental Information
11/30/20 (unaudited)
The fund is an investment company and accordingly follows the investment company accounting and reporting guidance of the Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic 946 Financial Services - Investment Companies.
(1) Investment Valuations
Equity securities, including restricted equity securities, are generally valued at the last sale or official closing price on their primary market or exchange as provided by a third-party pricing service. Equity securities, for which there were no sales reported that day, are generally valued at the last quoted daily bid quotation on their primary market or exchange as provided by a third-party pricing service. Short-term instruments with a maturity at issuance of 60 days or less may be valued at amortized cost, which approximates market value. Open-end investment companies are generally valued at net asset value per share. Securities and other assets generally valued on the basis of information from a third-party pricing service may also be valued at a broker/dealer bid quotation. In determining values, third-party pricing services can utilize both transaction data and market information such as yield, quality, coupon rate, maturity, type of issue, trading characteristics, and other market data. The values of foreign securities and other assets and liabilities expressed in foreign currencies are converted to U.S. dollars using the mean of bid and asked prices for rates provided by a third-party pricing service.
The Board of Trustees has delegated primary responsibility for determining or causing to be determined the value of the fund’s investments (including any fair valuation) to the adviser pursuant to valuation policies and procedures approved by the Board. If the adviser determines that reliable market quotations are not readily available, investments are valued at fair value as determined in good faith by the adviser in accordance with such procedures under the oversight of the Board of Trustees. Under the fund’s valuation policies and procedures, market quotations are not considered to be readily available for most types of debt instruments and floating rate loans and many types of derivatives. These investments are generally valued at fair value based on information from third-party pricing services. In addition, investments may be valued at fair value if the adviser determines that an investment’s value has been materially affected by events occurring after the close of the exchange or market on which the investment is principally traded (such as foreign exchange or market) and prior to the determination of the fund’s net asset value, or after the halt of trading of a specific security where trading does not resume prior to the close of the exchange or market on which the security is principally traded. Events that occur after foreign markets close (such as developments in foreign markets and significant movements in the U.S. markets) and prior to the determination of the fund’s net asset value may be deemed to have a material effect on the value of securities traded in foreign markets. Accordingly, the fund’s foreign equity securities may often be valued at fair value. The adviser generally relies on third-party pricing services or other information (such as the correlation with price movements of similar securities in the same or other markets; the type, cost and investment characteristics of the security; the business and financial condition of the issuer; and trading and other market data) to assist in determining whether to fair value and at what value to fair value an investment. The value of an investment for purposes of calculating the fund’s net asset value can differ depending on the source and method used to determine value. When fair valuation is used, the value of an investment used to determine the fund’s net asset value may differ from quoted or published prices for the same investment. There can be no assurance that the fund could obtain the fair value assigned to an investment if it were to sell the investment at the same time at which the fund determines its net asset value per share.
Various inputs are used in determining the value of the fund's assets or liabilities. These inputs are categorized into three broad levels. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment's level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fund's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the investment. Level 1 includes unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 includes other significant observable market-based inputs (including quoted prices for similar securities, interest rates, prepayment speed, and credit risk). Level 3 includes unobservable inputs, which may include the adviser's own assumptions in determining the fair value of investments. The following is a summary of the levels used as of November 30, 2020 in valuing the fund's assets or liabilities:
Financial Instruments Level 1 Level 2 Level 3 Total
Equity Securities:        
United States $48,610,826,208 $— $— $48,610,826,208
Switzerland 1,154,181,838 1,154,181,838
United Kingdom 241,751,382 743,855,907 985,607,289
Netherlands 557,939,715 557,939,715
Canada 343,095,571 343,095,571
France 179,322,752 179,322,752
Mutual Funds 650,034,619 650,034,619
Total $50,403,647,495 $2,077,360,497 $— $52,481,007,992
For further information regarding security characteristics, see the Portfolio of Investments.
4

Supplemental Information (unaudited) – continued
(2) Investments in Affiliated Issuers
An affiliated issuer may be considered one in which the fund owns 5% or more of the outstanding voting securities, or a company which is under common control. For the purposes of this report, the following were affiliated issuers:
Affiliated Issuers Beginning
Value
Purchases Sales
Proceeds
Realized
Gain
(Loss)
Change in
Unrealized
Appreciation or
Depreciation
Ending
Value
MFS Institutional Money Market Portfolio $688,394,733 $1,172,354,384 $1,210,714,498 $— $— $650,034,619
Affiliated Issuers Dividend
Income
Capital Gain
Distributions
MFS Institutional Money Market Portfolio $97,635 $—
(3) Impacts of COVID-19
The pandemic related to the global spread of novel coronavirus disease (COVID-19), which was first detected in December 2019, has resulted in significant disruptions to global business activity and the global economy, as well as the economies of individual countries, the financial performance of individual companies and sectors, and the securities and commodities markets in general. This pandemic, the full effects of which are still unknown, has resulted in substantial market volatility and may have adversely impacted the prices and liquidity of the fund's investments and the fund's performance.
5